Johnson & Johnson, the pharmaceutical giant with a 3.21% dividend yield, released financial results for Q2 2024 that exceeded my expectations. Its oncology franchise revenue was $5.09 billion for t...

Dividend stocks pay dividends to their shareholders, representing a portion of the company's profits. Not all companies offer dividends.

Johnson & Johnson's (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J, remains committed ...

Johnson & Johnson beats market estimates for revenue and EPS in Q2 FY24. A strong product pipeline includes new drugs for ulcerative colitis and lung cancer. JNJ's acquisition of Shockwave Medical ...

Johnson & Johnson (NYSE:JNJ) shares climbed 3% after second-quarter earnings fell less than expected.  Helped by 8% sales from its pharmaceutical arm, group revenue rose 4.3% to $22.45 billion, whi...

Johnson & Johnson (JNJ) reported mixed second-quarter results Wednesday, as one-time costs caused the company to miss profit estimates despite better-than-expected sales.

Johnson & Johnson executive vice president and CFO Joseph Wolk joins 'Squawk Box' to break down the company's quarterly earnings results, growth outlook, and more.

Johnson & Johnson and Medtronic are healthcare leaders that have faced their share of issues in recent years. Still, both companies have the innovative capabilities and expertise to succeed in the ...

With the 2024 Q2 earnings season kicking into a much higher gear next week, there are several reports investors should keep on their radars, including these three.

Recession-proof stocks offer investors a safe harbor to shield their portfolios from downside risk. The stock market has cooled off following its AI-powered surge for the last two years.

Johnson & Johnson will announce its Q2 2024 results on Wednesday, July 17 before the market opens. In this update, I share what to expect from JNJ's Q2 results and put previous results into perspec...

During stock investing, having a list of the top undervalued stocks can offer lucrative opportunities for value growth and portfolio stability. Here are three stocks whose intrinsic value exceeds t...

In an era where some investors prioritize stable income and reliable returns, artificial intelligence (AI) has identified three standout dividend stocks poised to shine in the latter half of 2024.

Johnson & Johnson reported solid first quarter results and is also expecting mid-single digit growth for the full year. The company is facing risks right now, especially from the litigations due to...

A federal judge on Friday rejected a bid by a group of cancer victims to block Johnson & Johnson from pursuing a proposed bankruptcy settlement of tens of thousands of lawsuits alleging the company...